O'Boyle NM - Search Results

1

Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.

McLoughlin EC, O'Boyle NM. McLoughlin EC, et al. Pharmaceuticals (Basel). 2020 Jan 3;13(1):8. doi: 10.3390/ph13010008. Pharmaceuticals (Basel). 2020. PMID: 31947889 Free PMC article. Review.

2

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells.

Wang S, Malebari AM, Greene TF, O'Boyle NM, Fayne D, Nathwani SM, Twamley B, McCabe T, Keely NO, Zisterer DM, Meegan MJ. Wang S, et al. Pharmaceuticals (Basel). 2019 Apr 11;12(2):56. doi: 10.3390/ph12020056. Pharmaceuticals (Basel). 2019. PMID: 30979033 Free PMC article.

3

Special Issue "Anticancer Drugs".

Meegan MJ, O'Boyle NM. Meegan MJ, et al. Pharmaceuticals (Basel). 2019 Sep 16;12(3):134. doi: 10.3390/ph12030134. Pharmaceuticals (Basel). 2019. PMID: 31527393 Free PMC article.

4

Correction: McLoughlin, E.C.; O'Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8.

McLoughlin EC, O'Boyle NM. McLoughlin EC, et al. Pharmaceuticals (Basel). 2020 Apr 20;13(4):72. doi: 10.3390/ph13040072. Pharmaceuticals (Basel). 2020. PMID: 32325955 Free PMC article.

5

Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity.

Ibrahim TS, Hawwas MM, Malebari AM, Taher ES, Omar AM, O'Boyle NM, McLoughlin E, Abdel-Samii ZK, Elshaier YAMM. Ibrahim TS, et al. Pharmaceuticals (Basel). 2020 Nov 15;13(11):393. doi: 10.3390/ph13110393. Pharmaceuticals (Basel). 2020. PMID: 33203182 Free PMC article.

6

Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer.

Ana G, Kelly PM, Malebari AM, Noorani S, Nathwani SM, Twamley B, Fayne D, O'Boyle NM, Zisterer DM, Pimentel EF, Endringer DC, Meegan MJ. Ana G, et al. Pharmaceuticals (Basel). 2021 Feb 22;14(2):169. doi: 10.3390/ph14020169. Pharmaceuticals (Basel). 2021. PMID: 33671674 Free PMC article.

7

Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4.

Malebari AM, Wang S, Greene TF, O'Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM, Meegan MJ. Malebari AM, et al. Pharmaceuticals (Basel). 2021 Oct 31;14(11):1119. doi: 10.3390/ph14111119. Pharmaceuticals (Basel). 2021. PMID: 34832901 Free PMC article.

8

29th Annual GP2A Medicinal Chemistry Conference.

Helesbeux JJ, Carro L, McCarthy FO, Moreira VM, Giuntini F, O'Boyle N, Matthews SE, Bayraktar G, Bertrand S, Rochais C, Marchand P. Helesbeux JJ, et al. Pharmaceuticals (Basel). 2021 Dec 7;14(12):1278. doi: 10.3390/ph14121278. Pharmaceuticals (Basel). 2021. PMID: 34959677 Free PMC article.

9

Special Issue "Anticancer Drugs 2021".

Meegan MJ, O'Boyle NM. Meegan MJ, et al. Pharmaceuticals (Basel). 2022 Apr 14;15(4):479. doi: 10.3390/ph15040479. Pharmaceuticals (Basel). 2022. PMID: 35455476 Free PMC article.

10

Application of 2D EXSY and qNMR Spectroscopy for Diastereomeric Excess Determination Following Chiral Resolution of β-Lactams.

McLoughlin EC, O'Brien JE, Trujillo C, Meegan MJ, O'Boyle NM. McLoughlin EC, et al. ChemistryOpen. 2023 Jun;12(6):e202200119. doi: 10.1002/open.202200119. Epub 2022 Jul 25. ChemistryOpen. 2023. PMID: 35876400 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page